Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells

Molecular Vision

Volumn 18, Issue , 2012, Pages 22-28

  Zhou, Peng ^a   Lu, Yi ^a   Sun, Xing Huai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA METHYLTRANSFERASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; ZEBULARINE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CATARACT; CELL ADHESION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFANT; LENS EPITHELIUM; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CAPSULE OPACIFICATION; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CYTIDINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; LENS CAPSULE, CRYSTALLINE; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863020791     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kohnen T, Fabian E, Gerl R, Hunold W, Hutz W, Strobel J, Hoyer H, Mester U. Optic edge design as long-term factor for posterior capsular opacification rates. Ophthalmology 2008; 115:1308-14. [PMID: 18321585]
2. Jiang YX, Lu Y, Liu TJ, Yang J, Chen Y, Fang YW. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification. Mol Vis 2011; 17:291-9. [PMID: 21283526]
3. Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 2009; 127:555-62. [PMID: 19365040]
4. Chan E, Mahroo OA, Spalton DJ. Complications of cataract surgery. Clin Exp Optom 2010; 93:379-89. [PMID: 20735786]
5. Bhagwandien AC, Cheng YY, Wolfs RC, van Meurs JC, Luyten GP. Relationship between retinal detachment and biometry in 4262 cataractous eyes. Ophthalmology 2006; 113:643-9. [PMID: 16527355]
6. Konno K, Nagamoto T. Membranous proliferation on the posterior surface of an intraocular lens after Nd:YAG laser capsulotomy. Jpn J Ophthalmol 2005; 49:173-5. [PMID: 15838738]
7. Zhou P, Lu Y, Sun XH. Zebularine suppresses TGF-betainduced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2. Mol Vis 2011; 17:2717-23. [PMID: 22065925]
8. Dwivedi RS, Herman JG, McCaffrey TA, Raj DS. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 2011; 79:23-32. [PMID: 20881938]
9. Hurd PJ, Whitmarsh AJ, Baldwin GS, Kelly SM, Waltho JP, Price NC, Connolly BA, Hornby DP. Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone. J Mol Biol 1999; 286:389-401. [PMID: 9973559]
10. Holleran JL, Parise RA, Joseph E, Eiseman JL, Covey JM, Glaze ER, Lyubimov AV, Chen YF, D'Argenio DZ, Egorin MJ. Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine. Clin Cancer Res 2005; 11:3862-8. [PMID: 15897587]
11. Beumer JH, Eiseman JL, Parise RA, Joseph E, Holleran JL, Covey JM, Egorin MJ. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice. Clin Cancer Res 2006; 12:7483-91. [PMID: 17138702]
12. Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, Selker EU. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst 2003; 95:399-409. [PMID: 12618505]
13. Scott SA, Lakshimikuttysamma A, Sheridan DP, Sanche SE, Geyer CR, DeCoteau JF. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. Exp Hematol 2007; 35:263-73. [PMID: 17258075]
14. Neureiter D, Zopf S, Leu T, Dietze O, Hauser-Kronberger C, Hahn EG, Herold C, Ocker M. Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models. Scand J Gastroenterol 2007; 42:103-16. [PMID: 17190770]
15. Zhou P, Zhao MW, Li XX, Yu WZ, Bian ZM. SiRNA targeting mammalian target of rapamycin (mTOR) attenuates experimental proliferative vitreoretinopathy. Curr Eye Res 2007; 32:973-84. [PMID: 18027173]
16. Hellebrekers DM, Jair KW, Vire E, Eguchi S, Hoebers NT, Fraga MF, Esteller M, Fuks F, Baylin SB, van Engeland M, Griffioen AW. Angiostatic activity of DNA methyltransferase inhibitors. Mol Cancer Ther 2006; 5:467-75. [PMID: 16505122]
17. Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 2006; 130:1117-28. [PMID: 16618406]
18. Billam M, Sobolewski MD, Davidson NE. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res Treat 2010; 120:581-92. [PMID: 19459041]
19. Kim SY, Kim JH, Choi JS, Joo CK. Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. Clin Experiment Ophthalmol 2007; 35:755-8. [PMID: 17997781]
20. Abdelwahab MT, Lindell I, Hultenby K, Kugelberg M. Transmission electron microscopy of the rabbit posterior capsule irrigated with thapsigargin and 5-fluorouracil in a sealed-capsule irrigation device. Eye (Lond) 2009; 23:975-8. [PMID: 18617905]
21. Eibl KH, Liegl R, Kernt M, Priglinger S, Kampik A. Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior capsule opacification. J Cataract Refract Surg 2009; 35:900-5. [PMID: 19393891]
22. Quintás-Cardama A, Tong W, Kantarjian H, Thomas D, Ravandi F, Kornblau S, Manshouri T, Cortes JE, Garcia-Manero G, Verstovsek S. A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/ polycythemia vera myelofibrosis. Leukemia 2008; 22:965-70. [PMID: 18385750]
23. Braiteh F, Soriano AO, Garcia-Manero G, Hong D, Johnson MM, Silva Lde P, Yang H, Alexander S, Wolff J, Kurzrock R. Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. Clin Cancer Res 2008; 14:6296-301. [PMID: 18829512]
24. Plummer R, Vidal L, Griffin M, Lesley M, de Bono J, Coulthard S, Sludden J, Siu LL, Chen EX, Oza AM, Reid GK, McLeod AR, Besterman JM, Lee C, Judson I, Calvert H, Boddy AV. Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. Clin Cancer Res 2009; 15:3177-83. [PMID: 19383817]